Citadel Advisors’s Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda) CYTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-14,802
| Closed | -$9.35K | – | 7097 |
|
|
2024
Q3 | $9.35K | Buy |
+14,802
| New | +$9.35K | ﹤0.01% | 5457 |
|
|
2023
Q4 | – | Sell |
-1,958
| Closed | -$9.45K | – | 6964 |
|
|
2023
Q3 | $9.45K | Sell |
1,958
-1,689
| -46% | -$8.15K | ﹤0.01% | 5442 |
|
|
2023
Q2 | $46.7K | Buy |
+3,647
| New | +$46.7K | ﹤0.01% | 5012 |
|
|
2022
Q4 | – | Sell |
-162
| Closed | -$19K | – | 6960 |
|
|
2022
Q3 | $19K | Buy |
+162
| New | +$19K | ﹤0.01% | 5551 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7220 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 7397 |
|
|
2021
Q4 | – | Sell |
-144
| Closed | -$116K | – | 7451 |
|
|
2021
Q3 | $116K | Buy |
+144
| New | +$116K | ﹤0.01% | 5768 |
|
|
2021
Q2 | – | Sell |
-114
| Closed | -$159K | – | 7308 |
|
|
2021
Q1 | $159K | Buy |
114
+89
| +356% | +$124K | ﹤0.01% | 5566 |
|
|
2020
Q4 | $26K | Buy |
+25
| New | +$26K | ﹤0.01% | 4955 |
|
|
2019
Q1 | – | Sell |
-3
| Closed | -$11K | – | 5173 |
|
|
2018
Q4 | $11K | Sell |
3
-4
| -57% | -$14.7K | ﹤0.01% | 4399 |
|
|
2018
Q3 | $21K | Buy |
+7
| New | +$21K | ﹤0.01% | 4130 |
|
|
2018
Q2 | – | Sell |
-3
| Closed | -$45K | – | 4691 |
|
|
2018
Q1 | $45K | Buy |
+3
| New | +$45K | ﹤0.01% | 3762 |
|
|
2017
Q4 | – | Hold |
0
| – | -$15K | – | 4379 |
|
|
2017
Q3 | – | Hold |
0
| – | -$14K | – | 3564 |
|
|
2017
Q2 | – | Hold |
0
| – | -$20K | – | 3564 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 3524 |
|
|
2016
Q4 | – | Hold |
0
| – | -$18K | – | 4235 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 3459 |
|